TH118854A - The agent to reduce or eliminate the use of steroids and methods of using this agent. - Google Patents

Abstract

DC60 (07/11/54) typically The invention involved the use of drugs to treat inflammatory bowel disease (IBD), asthma, Crohn's disease (CD), sclerosis (Ms), rheumatoid arthritis (RA), implant disease. Against host disease (GVHD) Host disease Against implantation And various types of spinal diseases Which consists of providing an immunoglobulin (immunoglobulin) in effective doses for reducing Or eliminate the use of steroids Or to patients who need these substances Generally This invention also involves As well as complementary therapies for the treatment of these conditions Generally The invention involved the use of drugs to treat inflammatory bowel disease (IBD), asthma, Crohn's disease (CD), MS (MS), rheumatoid arthritis (RA), implant disease. Against the host (GVHD) Host disease against implantation. And various types of spinal diseases This includes providing effective doses of immunoglobulins for the reduction or management of steroid use or to patients who need them. Generally This invention is also related to Complementary therapies for the treatment of these conditions.

Claims (1)

1. The use of agents to reduce or eliminate the use of steroids for the preparation of drugs for therapy. Organism to reduce And / or eliminates the need for steroid therapy in diseased organisms. Which were selected from the group containing inflammatory bowel disease, asthma, sclerosis Rheumatoid arthritis The disease spreads against the host. Host disease resists implants and different types of arthritic conditions. And all these diseases together This includes administering effective doses for steroid restriction. Tag: Drug Patents